CAMBRIDGE, Mass.--(BW HealthWire)--June 8, 2001--Alkermes, Inc. (NASDAQ:ALKS) announced today that its corporate presentation will be webcast live by the Goldman Sachs Healthcare Conference on Wednesday, June 13, 2001 at 10:40am ET (7:40am PT). Investors may access the webcast at http://www.gs.com/ir/conf. The user name to access the webcast is: conference/conf8 and the password is: goldman8. A replay of the presentation will be available 24 hours after the presentation for two months.
Richard Pops, Chief Executive Officer of Alkermes, Inc., will present an overview of the company at 10:40 a.m. ET (7:40am PT) on Wednesday, June 13, 2001, from the Ritz-Carlton Hotel, Laguna Niguel, DanaPoint, California.
Alkermes is a leader in the development of products based on sophisticated drug delivery technologies. Its first product, Nutropin Depot(TM), is a long-acting form of Genentech's recombinant human growth hormone using Alkermes' ProLease(R) technology. The company has several areas of focus, including (i) controlled, sustained release of injectable drugs lasting several days to several weeks, utilizing its ProLease and Medisorb(R) technologies and (ii) the development of pharmaceutical products based on proprietary pulmonary drug delivery technologies utilizing its AIR(TM) technology. In addition to its Cambridge, Massachusetts headquarters, research and manufacturing facilities, Alkermes operates research and manufacturing facilities in Ohio and a medical affairs office in Cambridge, England.
--30--mb/bos*
| CONTACT: | Alkermes, Inc. |
|---|---|
| Rebecca Peterson, (617) 583-6378 | |